StockData
Madrigal Pharmaceuticals, Inc. logo

Madrigal Pharmaceuticals, Inc. (MDGL) stock

MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/304% above fair value
$421.99−1.97 (-0.46%)

Close on Nov 17, 2026Market cap $9.75BP/E –Yield –

Madrigal Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Madrigal Pharmaceuticals's market cap was $10.00B on Nov 11, 2026, against $13.55B a year earlier. Over the last 5 years it ranged from $970.81M to $13.55B, with a median of $5.15B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$10.00B-24.4%
2025Dec 31, 2025$13.22B+96.5%
2024Dec 31, 2024$6.73B+57.2%
2023Dec 29, 2023$4.28B-13.8%
2022Dec 30, 2022$4.96B+247.5%
2021Dec 31, 2021$1.43B-16.9%
2020Dec 31, 2020$1.72B+22.3%
2019Dec 31, 2019$1.41B-19.0%
2018Dec 31, 2018$1.74B+51.3%
2017Dec 29, 2017$1.15B+565.3%
2016Dec 30, 2016$172.40M+339.2%
2015Dec 31, 2015$39.25M-83.3%
2014Dec 31, 2014$234.89M-20.3%
2013Dec 31, 2013$294.73M-35.1%
2012Dec 31, 2012$454.32M+141.5%
2011Dec 30, 2011$188.15M+10.7%
2010Dec 31, 2010$169.96M–

More Madrigal Pharmaceuticals figures

See a number that looks wrong?